Related Experiment Video
Updated: May 6, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Coronary Artery Disease and Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement
Aakash Garg1, Suleman Ilyas1, Michael Cryer2
1Division of Cardiology, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Insights
Coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve replacement (TAVR). Optimal management of CAD before and after TAVR requires further research to improve patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery disease (CAD) and aortic stenosis share common risk factors and pathophysiology.
- CAD is prevalent in up to 50% of patients evaluated for aortic valve replacement, impacting outcomes.
Purpose of the Study:
- To review current literature on CAD in patients undergoing transcatheter aortic valve replacement (TAVR).
- To focus on CAD prevalence, impact on outcomes, revascularization timing, and post-TAVR coronary intervention challenges.
Main Methods:
- Systematic literature review of studies on CAD in TAVR patients.
- Analysis of data regarding pre-TAVR CAD evaluation and revascularization strategies.
- Examination of outcomes and feasibility of coronary interventions after TAVR.
Main Results:
- CAD significantly affects outcomes in TAVR patients, particularly with severe disease.
- Optimal timing and indications for revascularization in TAVR patients remain under investigation.
- Limited data exists on the incidence, feasibility, and outcomes of percutaneous coronary intervention (PCI) post-TAVR.
Conclusions:
- The management of CAD in the expanding TAVR population requires further clarification.
- More research is needed on pre-TAVR CAD assessment and revascularization strategies.
- Understanding post-TAVR coronary interventions is crucial for comprehensive patient care.
Abstract:
Coronary artery disease (CAD) and aortic stenosis share similar risk factors and underlying pathophysiology. Up to half of the patient population undergoing work-up for aortic valve replacement have underlying CAD, which can affect outcomes in patients with more severe disease. As the indications for transcatheter aortic valve replacement (TAVR) have expanded to intermediate and now low risk patients, the optimal management of CAD in this patient population still needs to be determined. This includes both pre-TAVR evaluation for CAD as well as indications for revascularization in patients undergoing TAVR. There is also limited data on coronary interventions after TAVR, including the incidence, feasibility and outcomes of patients undergoing percutaneous coronary intervention (PCI) after TAVR. This review provides an updated report of the current literature on CAD in TAVR patients, focusing on its prevalence, impact on outcomes, timing of revascularization and potential challenges with coronary interventions post-TAVR.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care